BioSpace News Archive

Business

Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2024 after the market close on Tuesday, May 7th, 2024.

April 9, 2024
·
1 min read
Business

Vertex to Announce First Quarter 2024 Financial Results on May 6

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2024 financial results on Monday, May 6, 2024 after the financial markets close.

April 9, 2024
·
2 min read
Drug Development

Auron Unveils Preclinical Data Supporting its Lead Program and Ability of its AURIGIN™ Platform to Generate Targeted Cancer Therapies at AACR Annual Meeting

Auron Therapeutics announced two poster presentations at the American Association for Cancer Research Annual Meeting.

April 9, 2024
·
5 min read
Business

Dentsply Sirona to Host First Quarter Conference Call on May 2nd

DENTSPLY SIRONA Inc. announced that the Company will be hosting an investor conference call and live webcast on Thursday, May 2, 2024, at 8:30 am ET to review its first quarter financial results.

April 9, 2024
·
1 min read
BioMark to Advance Development of Cancer Treatment for Glioblastoma

BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) (“BioMark” or the “Company”) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today

April 9, 2024
·
4 min read
Genomics Market Size To Hit USD 157.47 Billion By 2033

The global genomics market size was valued at USD 33.90 billion in 2023 and is poised to grow from USD 39.53 billion in 2024 to USD 157.47 billion by 2033, growing at a CAGR of 16.6% in the forecast period (2024-2033).

April 9, 2024
·
15 min read
Biotech Bay

Q Bio Unveils New MRI Technology - Tensor Field Mapping - Advancing Measurement in Medical Imaging

Q Bio Inc. announced the launch of Tensor Field Mapping, a new technology for Magnetic Resonance Imaging that provides detailed insights into the human body that were previously unimaginable.

April 9, 2024
·
3 min read
Drug Development

RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients

RAPT Therapeutics, Inc. (Nasdaq: RAPT) today announced safety and efficacy data from its ongoing Phase 2 trial of tivumecirnon in combination with the anti-PD-1 checkpoint inhibitor (CPI) pembrolizumab in the cohort of patients with advanced head and neck squamous cell carcinoma (HNSCC) whose disease progressed despite previous treatment with CPI therapy (CPI-experienced).

April 9, 2024
·
6 min read
Biotech Bay

Nurix Therapeutics Reports First Clinical Evidence of CNS Activity of NX-5948, a Brain-Penetrant, Orally Available, BTK Degrader in Development for B Cell Malignancies

Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the presentation of the first findings of clinical responses in the brain for NX-5948, an orally available, selective degrader of Bruton’s tyrosine kinase (BTK).

April 9, 2024
·
8 min read
Genetown

Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting

Mural Oncology plc (Nasdaq: MURA) today shared poster presentations with pre-clinical data from its Interleukin-18 (IL-18) and IL-12 programs at the American Association for Cancer Research (AACR) annual meeting taking place April 5-10 in San Diego, California.

April 9, 2024
·
6 min read